Indivior Pharmaceuticals (INDV) Equity Ratio (2021 - 2026)

Indivior Pharmaceuticals' Equity Ratio history runs 6 years deep, the most recent figure standing at 0.12 for Q1 2026.

• In Q1 2026, Equity Ratio rose 41.96% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (up 41.96% YoY), while the FY2025 annual figure was 0.08, up 68.14% from the prior year.
• Equity Ratio was 0.12 for Q1 2026 at Indivior Pharmaceuticals, down from 0.08 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.01 in Q4 2022 to a low of 0.26 in Q4 2024.
• Historically, Equity Ratio has averaged 0.14 across 5 years, with a median of 0.13 in 2025.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio slumped 1134.34% in 2023, then jumped 68.14% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.01 in 2022, then plunged by 1134.34% to 0.1 in 2023, then plunged by 144.67% to 0.26 in 2024, then surged by 68.14% to 0.08 in 2025, then tumbled by 47.43% to 0.12 in 2026.
• The last three Equity Ratio figures came in at 0.12 (Q1 2026), 0.08 (Q4 2025), and 0.15 (Q3 2025), per Business Quant data.